Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

421.50p

Change Today:

3.50p
52 Week High: 428.00p
52 Week Low: 166.80p

Currency: UK Pounds
Shares Issued: 105.36m
Volume: 26,118

Market Cap: £444.09m
RiskGrade: 125

Trade now with Barclays Stockbrokers

Update -Oxford Biomedica is a top riser in its sector - discover how to spread bet similar stocks Find out more

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

6 Month Chart

More Oxford Biomedica charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-205.7%	-31.0%
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	4.9	3.2
Pr/Book	5.7

	Latest	F'cast
Revenue	-36.0%	45.3%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

OXB Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	64.06	(20.89)	(22.10)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	87.73	(6.57)	(7.81)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	142.80	19.88	22.77p	54.0	n/a	n/a	n/a	0.0%
31-Dec-22	139.99	(45.98)	(41.29)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	89.54	(188.53)	(163.11)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-24	130.07	(40.34)	(38.95)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	167.05	(18.94)	(21.77)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-26	211.33	5.32	(2.42)p	n/a	n/a	n/a	n/a	0.0%

Oxford Biomedica forecasts

OXB Company Announcements

Block Listing Application	21-Oct-2024	09:47	RNS
Grant of Options	04-Oct-2024	15:25	RNS
Holding(s) in Company	03-Oct-2024	16:05	RNS

More Oxford Biomedica oxb company announcements

OXB ShareCast News

Oxford Biomedica reports first-half revenue growth	23-Sep-2024	ShareCast
Oxford Biomedica still expecting small loss afte...	08-Aug-2024	ShareCast
Oxford Biomedica appoints new finance chief	17-Jul-2024	ShareCast

More Oxford Biomedica ShareCast news

OXB Top Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ...	16-Aug-2008	Times
Need to know	10-May-2008	Times
DSG International may be losing its spark	12-Feb-2008	Telegraph

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

OXB Market Data

Currency	UK Pounds
Share Price	421.50p
Change Today	3.50p
% Change	0.84 %
52 Week High	428.00p
52 Week Low	166.80p
Volume	26,118
Shares Issued	105.36m
Market Cap	£444.09m
RiskGrade	125